Cargando…
Role of concomitant therapy for Helicobacter pylori eradication: A technical note
We read with interest the recent meta-analysis by Lin et al who evaluated the effectiveness of concomitant regimen for Helicobacter pylori (H. pylori) in Chinese regions. They found that 7-d concomitant regimen is undoubtedly superior to 7-d triple therapy (91.2% vs 77.9%, P < 0.0001). However, i...
Autores principales: | Losurdo, Giuseppe, Giorgio, Floriana, Iannone, Andrea, Principi, Mariabeatrice, Barone, Michele, Di Leo, Alfredo, Ierardi, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064046/ https://www.ncbi.nlm.nih.gov/pubmed/27784977 http://dx.doi.org/10.3748/wjg.v22.i38.8638 |
Ejemplares similares
-
Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
por: Ierardi, Enzo, et al.
Publicado: (2017) -
Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018) -
A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
por: Losurdo, Giuseppe, et al.
Publicado: (2016) -
The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science
por: Ierardi, Enzo, et al.
Publicado: (2020) -
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
por: Ierardi, Enzo, et al.
Publicado: (2019)